Allozyne Headquarters
The links below provide all the necessary information about Allozyne Headquarters. Also there you will find information about the address, phone numbers, emails and much more.
Allozyne - Crunchbase Company Profile & Funding
- https://www.crunchbase.com/organization/allozyne
- Headquarters Regions Greater Seattle Area, West Coast, Western US Founded Date 2005 Founders David A. Tirrell, Dee Datta, William A. Goddard Operating Status Active Last Funding Type Debt Financing Company Type For Profit Contact …
Allozyne, Inc. Company Profile | Seattle, WA
- https://www.dnb.com/business-directory/company-profiles.allozyne_inc.e951a4b7fa0c74c16103145639dadf07.html
- Company Description: Allozyne, Inc. is located in Seattle, WA, United States and is part of the Scientific Research and Development Services Industry. Allozyne, Inc. has 16 total employees across all of its locations and generates $1.01 million in sales (USD). (Sales figure is modelled). Key Principal: Meenu Chhabra See more contacts.
ALLOZYNE | LinkedIn
- https://www.linkedin.com/company/allozyne
- Headquarters Seattle, WA Type Privately Held Founded 2005 Specialties Site-Specific Bioconjugation, Oncology, Antibody-Drug Conjugates, and Autoimmunity & Inflammation Locations Primary 1600...
Allozyne’s Competitors, Revenue, Number of Employees, …
- https://www.owler.com/company/allozyne
- Allozyne Headquarters 999 3rd Ave Suite 300 Seattle, Washington98104 206-674-3028 Driving Directions » Allozyne Summary ABOUT Overview Allozyne provides novel protein therapeutic product for inflammatory diseases, and cancer. Allozyne was founded in 2004. Allozyne's headquarters is located in Seattle, Washington, USA 98104.
Allozyne Inc - Company Profile and News - Bloomberg …
- https://www.bloomberg.com/profile/company/9055105Z:US
- Company profile page for Allozyne Inc including stock price, company news, press releases, executives, board members, and contact information
Allozyne, Inc. Sold For Scrap As MedImmune Snaps Up Rights
- https://www.biospace.com/article/allozyne-inc-sold-for-scrap-as-medimmune-snaps-up-rights-/
- Seattle-based biotech Allozyne has been quietly broken up and sold, with most of its patents and technologies sold to AstraZeneca (AZN) unit MedImmune, the company announced Friday. Allozyne said most of its assets were sold off earlier this summer to a previous licensing partner, reported tech website Xconomy.
Home - Allozymes
- https://www.allozymes.com/
- At Allozymes, we employ our proprietary microfluidics technology to build our next generation enzyme engineering platform. Our platform can build and test millions of enzymes per day, boosting the likelihood of success by 200X in developing the most effective enzymes. We have developed oxidase, reductases, isomerases, and hydrolases for our ...
Allozyne, Inc. - MPM Capital
- https://www.mpmcapital.com/companies/allozyne-inc/
- Allozyne was dedicated to developing technologies and therapeutics that address key unmet medical need in cancer and inflammatory diseases. Allozyne was acquired by …
Allozyne » ADC Review
- https://www.adcreview.com/resource-guide/allozyne/
- PK profile similar to parental antibody Biophysical properties that reduce aggregate formation Simplified and more efficient manufacturing processSite-specific bioconjugation to NNAAs recognized by FDA as a key next generation approach 1600 Fairview Ave E., Suite 300. Seattle, WA 98102 U.S.A. Web: Allozyne Advertisement #3 Advertisement #4
Allozyne lands $30M, hires veteran as CEO - Puget Sound …
- https://www.bizjournals.com/seattle/stories/2007/10/29/story7.html
- Allozyne's core technology sprang from laboratories of David Tirrell and William Goddard, at the California Institute of Technology in Pasadena. The two scientists developed a way to use synthetic...
Allozyne, Inc. - Seattle, Washington (WA) @ BiosciRegister.com
- https://www.biosciregister.com/Allozyne_Inc/Supplier/sid4013.htm
- E-Mail: info allozyne.com. Address: 1600 Fairview Ave E., Suite 300, Seattle, Washington 98102, USA. Phone: +1- (206)-518.5700 | Fax: +1- (206)-518.5799 | Map/Directions >>. Loading Map... Profile: Allozyne, Inc. is a protein optimization company that develops improved biological therapeutics to treat multiple areas of medical need. We focus on ...
Allozyne-Poniard merger called off | The Seattle Times
- https://www.seattletimes.com/business/allozyne-poniard-merger-called-off/
- Boeing moving headquarters to Virginia ; ... Allozyne had $5.7 million in operating expenses for the year’s first half, and has accumulated …
Poniard booted off Nasdaq after failed merger with Allozyne
- https://www.geekwire.com/2012/poniard-faces-nasdaq-delisting-failed-merger-allozyne/
- Allozyne, a six-year-old biotech upstart backed by OVP Venture Partners, Arch Venture Partners and others, had hoped to use the assets of Poniard to go public. The companies entered into a merger...
Allozyne, Inc. Closes $30 Million Series B Financing ... - BioSpace
- https://www.biospace.com/article/releases/allozyne-inc-closes-30-million-series-b-financing-appoints-new-president-and-ceo-/
- SEATTLE-- (BUSINESS WIRE)--Allozyne, Inc., a Seattle-based biotechnology company focused on the development and manufacture of improved protein therapeutics, announced today that it has closed a $30 million Series B financing.
Did you find out everything you wanted about Allozyne Headquarters?
We are sure that the information collected for you about Allozyne Headquarters turned out to be more than enough.
